Drug Information
Drug Generic Name | BROMAZEPAM |
Drug Class | HYPNOTICS, SEDATIVES AND ANXIOLYTICS |
Chapter | Central Nervous System |
Indications: short-term treatment of anxiety and associated states. Cautions: rebound or withdrawal symptoms following abrupt withdrawal; elderly patients; hepatic disease, renal impairment, obesity. Contra-indications: myasthenia gravis, narrow angle glaucoma, severe hepatic or respiratory disease, sleep apnoea, pregnancy and breast-feeding. Side Effects: Hypotension, palpitation, tachycardia; drowsiness, ataxia, dizziness, confusion, depression etc, rash, pruritis; nausea, vomiting, xerostomia; incontinence, decrease in libido; weakness, muscle spasm; blurred vision, depth perception decreased. Dose: 3-18 mg daily in divided doses. Elderly patients half adult dose. Max. (in hospitalized patients) 60 mg daily in divided doses. |
|
Brand Name |
|